- Global Pharma News & Resources

Global Drug Delivery Market Outlook 2020 (COVID 19 Impact Analysis)| Size,New Technologies,Services,Solutions,Trends,Geographical Analysis By 2027|Key Players-Novartis AG, F. Hoffmann-la Roche Ltd, Bayer AG, Pfizer Inc., 3M

Data Bridge Market Research recently released a research report on the Drug delivery analysis, which studies the Drug delivery industry coverage, current market competitive status, and market outlook and forecast by 2027. This Drug delivery report gives a total examination of the market on the worldwide and local levels. It examines the improvement rate and the market esteem subject to the market components and development starting variables. The market players are profiled and their improvement systems are isolated in order to oversee new members just as set up players. It moreover includes the start to finish examination of various unequivocal boundaries. This Drug delivery report additionally offers different systems for boosting the introduction of the associations.

Drug delivery market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 8.0% in the forecast period of 2020 to 2027 and expected to reach USD 2,378.99 billion by 2027.

Get Exclusive Sample (350 Pages PDF) of Drug delivery Market Report: To Know the Impact of COVID-19 on this Industry @

The major players covered in the report are

  • Johnson & Johnson Services, Inc.,
  • Novartis AG,
  • F. Hoffmann-la Roche Ltd,
  • Bayer AG,
  • Pfizer Inc., 3M,
  • Antares Pharma,
  • GlaxoSmithKline Plc,
  • Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.),
  • Nemera and Sanofi

Many product developments are also initiated by the companies worldwide which are also accelerating the growth of Drug delivery market.

For instance,

  • In February 2020, Novartis AG stated that both the FDA and European Medicines Agency EMA have acknowledged the supplemental biologics license application (sBLA) and marketing authorization application (MAA), for ofatumumab (OMB157) which is used to treat lapsing forms of multiple sclerosis.
  • In December 2019, Janssen Pharmaceutical Companies of Johnson & Johnson Services, Inc. took over the investigational bermekimab from Xbiotech Inc., this is bound to increase their already wide product portfolio and also it will increase the revenue of the company in the market.

What are the major market growth drivers?

Rising acceptance of self-administering drugs and increasing awareness about diagnosis and treatment around the globe is a driving factor for the market growth.

Drug delivery market has increased with technological development and the growth in the development of biologics in the developed as well as developing countries.

Rising prevalence of chronic and non-chronic disease has increased the market for drug delivery devices as the numbers of people that are being treated are more and also the latest technological development has led to the treatment of very rare and impossible to treat diseases, therefore more people will be attracted towards them.

Currently, various research studies are taking place which is anticipated to create a competitive advantage for manufacturers to create novel and inventive drug delivery devices and expected to offer various other opportunities in the drug delivery market.

For More Information In the Analysis of Reports Please Visit

Global Drug Delivery Market Scope and Market Size

Global drug delivery market is segmented on the basis of product type, end user, and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product type, the market is segmented into oral drug delivery, pulmonary drug delivery, injectable drug delivery, opthalmic drug delivery, nasal drug delivery, topical drug delivery, implantable drug delivery and transmucosal drug delivery. In 2020, oral drug delivery segment is expected to dominate the market due to the high reception of oral drug delivery route of administration by the patients as it is one of the humblest, convenient, and harmless routes for drug administration.
  • On the basis of end user, the market is segmented into hospitals, community healthcare, home healthcare, clinics and others. In 2020, hospitals segment is expected to dominate the market as hospitals are the first contact points for various types of treatments and surgical procedures, also the needs of all the in-house patients are catered.
  • On the basis of distribution channel, the market is segmented into hospital pharmacies, pharmacy stores, direct tenders and online pharmacy. In 2020, direct tenders segment is expected to dominate the market as cost benefits are provided to end users by direct tenders as compared to retail sales as well as direct tenders right away supply drug delivery devices from manufacturer to hospitals, dermatological clinics and others.

In-depth analysis of the market

  1. Comprehensive quantitative analysis of the industry is provided for the period of 2020-2027 to assist stakeholders to capitalize on the prevailing market opportunities.
  2. Comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
  3. The key findings and recommendations highlight crucial progressive industry trends in the drug delivery Market, thereby allowing players to develop effective long term strategies
  4. To analyze opportunities in the market for stakeholders by identifying the high-growth segments of the drug delivery market
  5. The various opportunities in the market.

TOC of drug delivery Market Report Contains: –

  • Industry Overview
  • Production Market Analysis
  • Sales Market Analysis
  • Consumption Market Analysis
  • Production, Sales and Consumption Market Comparison Analysis
  • Major Manufacturers Production and Sales Market Comparison Analysis
  • Major Type of drug delivery Analysis
  • Major Organization Size Analysis
  • Industry Chain Analysis
  • Global and Regional Market Forecast
  • Major Manufacturers Analysis
  • New Project Investment Feasibility Analysis
  • And More…

Table Of Contents Is Available Here@

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing . We are content with our glorious 99.9 % client satisfying rate.


Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 14-Aug-2020